Serial Number | 79250207 |
Word Mark | VETTER-JECT |
Filing Date | Monday, September 24, 2018 |
Status | 700 - REGISTERED |
Status Date | Tuesday, July 19, 2022 |
Registration Number | 6791709 |
Registration Date | Tuesday, July 19, 2022 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, May 3, 2022 |
Goods and Services | Bottling services, namely, bottling of liquid and solid substances, in particular of pharmaceuticals, medicines and solutions |
Goods and Services | Pharmaceutical preparations and medicines for the treatment of infections, cancer, depression, heart disease, vascular disease, intestinal disorder, lung and bronchial disfunction, liver disfunction, inflammation and inflammatory diseases, oral and laryngeal disease, optical and cranial disorders, arthritis, migraine, mucopolysaccharidosis, haemophilia, multiple sclerosis, osteoporosis, neuronal disorders, diabetes, erectile disfunction, infertility, crohn's disease, hereditary angioedema, thrombosis, encephalitis, diseases of the thyroid or parathyroid glands, metabolic diseases, muscular atrophy, disturbance of growth and anemia; pharmaceutical solutions for oral administration in the nature of sterile aseptic solutions, namely in the form of tablets, pills, capsules, drops, medical juice and medical syrup, all for the treatment of infections, cancer, depression, heart disease, vascular disease, intestinal disorder, lung and bronchial disfunction, liver disfunction, inflammation and inflammatory diseases, oral and laryngeal disease, optical and cranial disorders, arthritis, migraine, mucopolysaccharidosis, haemophilia, multiple sclerosis, osteoporosis, neuronal disorders, diabetes, erectile disfunction, infertility, crohn's disease, hereditary angioedema, thrombosis, encephalitis, diseases of the thyroid or parathyroid glands, metabolic diseases, muscular atrophy, disturbance of growth and anemia; injectable pharmaceuticals in the nature of antibody solutions, biologicals, peptides, polypeptides, proteins, enzymes, nucleic acids, coagulation factors, interferons, phosphonates and bisphosphonates, growth factors, hormones, hormoneantagonists, insulin, heparins, low molecular heparins and sulfur hexafluoride, all for the treatment of infections, cancer, depression, heart disease, vascular disease, intestinal disorder, lung and bronchial disfunction, liver disfunction, inflammation and inflammatory diseases, oral and laryngeal disease, optical and cranial disorders, arthritis, migraine, mucopolysaccharidosis, haemophilia, multiple sclerosis, osteoporosis, neuronal disorders, diabetes, erectile disfunction, infertility, crohn's disease, hereditary angioedema, thrombosis, encephalitis, diseases of the thyroid or parathyroid glands, metabolic diseases, muscular atrophy, disturbance of growth and anemia; eyedrops, contact lens solutions; medicated compresses; medical plasters, materials for dressings in the nature of bandages, wadding and gauze; filled medical injection devices, in particular syringes and instruments for injections, injectors, auto-injectors and single-chamber and dual-chamber disposable syringes, all sold filled with pharmaceutical preparations for the treatment of infections, cancer, depression, heart disease, vascular disease, intestinal disorder, lung and bronchial disfunction, liver disfunction inflammation and inflammatory diseases, oral and laryngeal disease, optical and cranial disorders, arthritis, migraine, mucopolysaccharidosis, haemophilia, multiple sclerosis, osteoporosis, neuronal disorders, diabetes, erectile disfunction, infertility, crohn's disease, hereditary angioedema, thrombosis, encephalitis, diseases of the thyroid or parathyroid glands, metabolic diseases, muscular atrophy, disturbance of growth and anemia |
Pseudo Mark | VETTER-INJECT |
Goods and Services | Empty medical injection devices, in particular syringes and instruments for injections, injectors, auto-injectors and single-chamber and dual-chamber disposable syringes, all sold empty; medicine containers for administering medicines, of glass and/or plastic in the nature of medical syringes, injectors, auto-injectors, disposable syringes and disposable cannulae; syringe holders being containers specially adapted for holding medical syringes; medical syringes, disposable syringes, and disposable cannulae sold either individually or in combination, all for medical purposes |
Goods and Services | Development of syringes and instruments for injections, injectors and packaging for the aforesaid goods; laboratory tests in the nature of scientific testing in the fields of chemical, physics and process engineering; product development and conducting of scientific tests in the fields of pharmacological and microbiological processes |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, January 28, 2019 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 6 - Active |
Class Status Date | Monday, January 28, 2019 |
Primary Code | 010 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 039 - Transport; packaging and storage of goods; travel arrangement. |
US Class Codes | 100, 105 |
Class Status Code | 6 - Active |
Class Status Date | Monday, January 28, 2019 |
Primary Code | 039 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, January 28, 2019 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Vetter Pharma-Fertigung GmbH & Co. KG |
Party Type | 30 - Original Registrant |
Legal Entity Type | 13 - Limited Partnership |
Address | DE |
Party Name | Vetter Pharma-Fertigung GmbH & Co. KG |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 13 - Limited Partnership |
Address | DE |
Party Name | Vetter Pharma-Fertigung GmbH & Co. KG |
Party Type | 10 - Original Applicant |
Legal Entity Type | 13 - Limited Partnership |
Address | DE |
Event Date | Event Description |
Monday, November 14, 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Saturday, October 22, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
Saturday, October 22, 2022 | FINAL DISPOSITION PROCESSED |
Wednesday, October 19, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Tuesday, July 19, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Tuesday, July 19, 2022 | REGISTERED-PRINCIPAL REGISTER |
Monday, May 9, 2022 | NOTIFICATION PROCESSED BY IB |
Tuesday, May 3, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, May 3, 2022 | PUBLISHED FOR OPPOSITION |
Wednesday, April 13, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, April 13, 2022 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Wednesday, April 13, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Sunday, March 27, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Saturday, March 26, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, March 25, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, March 25, 2022 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Monday, September 27, 2021 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED |
Monday, September 27, 2021 | CONTINUATION OF FINAL REFUSAL E-MAILED |
Monday, September 27, 2021 | ACTION CONTINUING A FINAL - COMPLETED |
Wednesday, July 28, 2021 | SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION |
Sunday, May 16, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
Wednesday, April 28, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, April 28, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
Friday, October 2, 2020 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
Thursday, March 12, 2020 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Thursday, March 12, 2020 | LETTER OF SUSPENSION E-MAILED |
Thursday, March 12, 2020 | SUSPENSION LETTER WRITTEN |
Tuesday, March 10, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, March 10, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, March 10, 2020 | ASSIGNED TO LIE |
Wednesday, March 4, 2020 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Thursday, March 5, 2020 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Thursday, March 5, 2020 | LETTER OF SUSPENSION E-MAILED |
Thursday, March 5, 2020 | SUSPENSION LETTER WRITTEN |
Friday, December 6, 2019 | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
Friday, November 29, 2019 | CORRECTION TRANSACTION RECEIVED FROM IB |
Thursday, September 5, 2019 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Thursday, September 5, 2019 | FINAL REFUSAL E-MAILED |
Thursday, September 5, 2019 | FINAL REFUSAL WRITTEN |
Tuesday, August 13, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, August 13, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, August 13, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Saturday, March 2, 2019 | REFUSAL PROCESSED BY IB |
Wednesday, February 13, 2019 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Tuesday, February 12, 2019 | REFUSAL PROCESSED BY MPU |
Tuesday, February 5, 2019 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Monday, February 4, 2019 | NON-FINAL ACTION WRITTEN |
Friday, February 1, 2019 | APPLICATION FILING RECEIPT MAILED |
Monday, January 28, 2019 | ASSIGNED TO EXAMINER |
Monday, January 28, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Thursday, January 24, 2019 | SN ASSIGNED FOR SECT 66A APPL FROM IB |